MVI 200 clinical trials
Also written MVI 200.
How each study uses MVI 200 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
MVI 100 (1) · MVI 150 (1)
Studies
Open first, then newest update. How each study uses MVI 200 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal DeliveryCompletedPhase 3Ferring PharmaceuticalsNCT01127581Written as MVI 200How we know
- Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of LaborCompletedPhase 2Ferring PharmaceuticalsNCT00828711Written as MVI 200How we know
- Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)CompletedPhase 2Ferring PharmaceuticalsNCT01283022Written as MVI 200How we know